Access cutting-edge sickle cell disease treatment through this clinical trial at a research site in Commack. Study-provided care at no cost to qualified participants.
Access sickle cell disease specialists in Commack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sickle cell disease treatment provided free
Hematopoietic Cell Transplantation/HCT involves receiving healthy blood-forming cells (stem cells) from a donor to replace the diseased or damaged cells in participants' bone marrow. The researchers think giving participants treatment with fludarabine and dexamethasone, drugs that lower the activity of the body's immune system (immune suppression), before standard conditioning therapy and HCT may help prevent serious side effects, including graft failure and GvHD. In this study, depending on how
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this sickle cell disease clinical trial in Commack, NY
If you're searching for sickle cell disease treatment options in Commack, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Commack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sickle cell disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.